查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566944

臨床決策支援平台市場：按組件、交付格式、應用程式和最終用戶分類：2024-2033 年全球機會分析和產業預測

Clinical Decision Support Platform Market By Component , By Delivery Mode By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

臨床決策支援平台市場

2023年臨床決策支援平台市場價值為12億美元，預計2024年至2033年複合年成長率為7.3%，到2033年達到24億美元。

臨床決策支援平台是旨在透過完善決策流程來增強醫療保健服務的系統。該平台將患者資料和健康記錄與現有資料庫和評估進行比較，並提供量身定做的建議。該平台旨在透過準確的診斷、最佳化的​​治療計劃、減少錯誤和遵守適當的實踐來提高醫療保健服務的品質。

各地區醫療保健和病人安全支出的增加正在推動臨床決策支援平台市場的成長。臨床決策支援平台也面臨很高的需求，因為它們有助於最佳化資源利用，並透過減少不必要的再入院病例來幫助降低成本。在數位時代，利用人工智慧和深度學習特性的臨床決策支援平台備受關注。人工智慧使得在短時間內準確評估和解釋大量資料成為可能。此外，深度學習透過預測分析、模式分析和影像識別補充了人工智慧的特性。

然而，安裝和維護平台以及建立必要的資源和基礎設施是一個昂貴的過程，這成長抑制因素。此外，這些平檯面臨資料外洩和網路攻擊的高風險，阻礙了市場開拓。例如，美國醫療保健公司 Change Healthcare 在 2024 年 2 月成為勒索軟體攻擊的目標，​​由於未授權存取，數百萬美國人的健康資料受到損害。

按部門審查

臨床決策支援平台市場分為組件、交付格式、應用程式、最終用戶和區域。按組件分類，市場分為軟體和服務。根據提供形式的不同，分為本地部署和雲端基礎。依用途分為藥物過敏警示、臨床指引、藥物交互作用、臨床提醒等。依最終用戶分類，可分為醫院、診所、門診醫療中心和學術/研究機構。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

從組成部分來看，軟體產業將在 2023 年佔據市場主導地位。

從交付模式來看，本地部署細分市場在 2023 年佔據了較高的市場。

從應用來看，藥物交互作用領域在2023年佔據了較高的市場佔有率。

按最終用戶分類，醫院細分市場在 2023 年將佔據較高市場佔有率。

按地區分類，北美地區 2023 年收益最高。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 贖回場景

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章臨床決策支援平台市場：按組成部分

  • 市場概況
  • 軟體
  • 服務

第5章 臨床決策支援平台市場：依規定格式

  • 市場概況
  • 本地
  • 雲端基礎

第6章臨床決策支援平台市場：依應用分類

  • 市場概況
  • 藥物過敏警告
  • 臨床指引
  • 藥物間相互作用
  • 臨床提醒
  • 其他

第7章 臨床決策支援平台市場：依最終使用者分類

  • 市場概況
  • 醫院
  • 診所
  • 門診治療中心
  • 學術研究所

第8章臨床決策支援平台市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國臨床決策支援平台市場
    • 加拿大臨床決策支援平台市場
    • 墨西哥臨床決策支援平台市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國臨床決策支援平台市場
    • 德國臨床決策支援平台市場
    • 義大利臨床決策支援平台市場
    • 西班牙臨床決策支援平台市場
    • 英國臨床決策支援平台市場
    • 其他歐洲國家臨床決策支援平台市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國臨床決策支援平台市場
    • 日本臨床決策支援平台市場
    • 印度臨床決策支援平台市場
    • 韓國臨床決策支援平台市場
    • 澳洲臨床決策支援平台市場
    • 其他亞太臨床決策支援平台市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西臨床決策支援平台市場
    • 南非臨床決策支援平台市場
    • 沙烏地阿拉伯臨床決策支援平台市場
    • 其他拉丁美洲/中東/非洲臨床決策支援平台市場

第9章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第10章 公司簡介

  • Cerner Corporation
  • EPIC Systems Corporation
  • IBM
  • Change Healthcare Corporation
  • Medical Information Technology Inc
  • Koninklijke Philips NV
  • Siemens Healthcare
  • Allscripts Healthcare Solutions Inc.
  • Wolters Kluwer NV
  • McKesson Corporation.
簡介目錄
Product Code: A323980

Clinical Decision Support Platform Market

The clinical decision support platform market was valued at $1.2 billion in 2023 and is projected to reach $2.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

Clinical decision support platform is a system designed to enhance the delivery of healthcare by refining the decision-making process. The platform compares patient data & health records with the existing database & assessments and provides tailored recommendations. The aim of the platform is to elevate the quality of healthcare delivery through precise diagnoses, optimized treatment plans, reduced errors, and strict adherence to appropriate practices.

Increase in expenditure of healthcare and patient safety across different regions is driving the growth of the clinical decision support platform market. In addition, the clinical decision support platform is witnessing a high demand as it aids in cost savings by facilitating the optimal usage of resources and reducing the cases of unnecessary hospital readmissions. In the digital era, clinical decision support platforms powered by the properties of AI and deep learning are gaining prominence. AI enables the precise assessment and interpretation of loads of data in a short span of time. Moreover, deep learning complements the attributes of AI through predictive analysis, pattern analysis, and image recognition.

However, the installation and maintenance of the platform, along with the assembly of necessary resources & infrastructure is an expensive process that restraints the growth of the clinical decision support platform market. Furthermore, these platforms remain at a high risk of data breach and cyberattacks, which hampers the market development. For instance, Change Healthcare-an American healthcare company-was targeted to a ransomware attack on February 2024, risking the health data of millions of Americans due to unauthorized access.

Segment Review

The clinical decision support platform market is segmented into component, delivery mode, application, end user, and region. On the basis of component, the market is bifurcated into software and services. As per delivery mode, it is divided into on-premises and cloud based. Depending on application, it is classified into drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders, and others. By end user, it is categorized into hospitals, clinics, ambulatory care centers, and academic & research institutes. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of component, the software segment dominated the market in 2023.

As per delivery mode, the on-premises segment acquired a high stake in the market in 2023.

Depending on application, the drug-drug interactions segment accounted for a high market share in 2023.

By end user, the hospitals segment was the highest shareholder of the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global clinical decision support platform market include Cerner Corporation, EPIC Systems Corporation, IBM, Change Healthcare Corporation, Medical Information Technology Inc, Koninklijke Philips NV, Siemens Healthcare, Allscripts Healthcare Solutions Inc., Wolters Kluwer NV, and McKesson Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Component

  • Software
  • Services

By Delivery Mode

  • On-Premises
  • Cloud Based

By Application

  • Drug Allergy Alerts
  • Clinical Guidelines
  • Drug-Drug Interactions
  • Clinical Reminders
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Academic and Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Cerner Corporation
    • EPIC Systems Corporation
    • IBM
    • Change Healthcare Corporation
    • Medical Information Technology Inc
    • Koninklijke Philips NV
    • Siemens Healthcare
    • Allscripts Healthcare Solutions Inc.
    • Wolters Kluwer NV
    • McKesson Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Component
  • 4.2. Software
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Services
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Delivery Mode
  • 5.2. On-Premises
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Cloud Based
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Drug Allergy Alerts
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Clinical Guidelines
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Drug-Drug Interactions
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Clinical Reminders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Others
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Hospitals
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinics
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Ambulatory Care Centers
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Academic And Research Institutes
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country

CHAPTER 8: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Component
    • 8.2.3. Market Size and Forecast, By Delivery Mode
    • 8.2.4. Market Size and Forecast, By Application
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Clinical Decision Support Platform Market
      • 8.2.7.1. Market Size and Forecast, By Component
      • 8.2.7.2. Market Size and Forecast, By Delivery Mode
      • 8.2.7.3. Market Size and Forecast, By Application
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Clinical Decision Support Platform Market
      • 8.2.8.1. Market Size and Forecast, By Component
      • 8.2.8.2. Market Size and Forecast, By Delivery Mode
      • 8.2.8.3. Market Size and Forecast, By Application
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Clinical Decision Support Platform Market
      • 8.2.9.1. Market Size and Forecast, By Component
      • 8.2.9.2. Market Size and Forecast, By Delivery Mode
      • 8.2.9.3. Market Size and Forecast, By Application
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Component
    • 8.3.3. Market Size and Forecast, By Delivery Mode
    • 8.3.4. Market Size and Forecast, By Application
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Clinical Decision Support Platform Market
      • 8.3.7.1. Market Size and Forecast, By Component
      • 8.3.7.2. Market Size and Forecast, By Delivery Mode
      • 8.3.7.3. Market Size and Forecast, By Application
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. Germany Clinical Decision Support Platform Market
      • 8.3.8.1. Market Size and Forecast, By Component
      • 8.3.8.2. Market Size and Forecast, By Delivery Mode
      • 8.3.8.3. Market Size and Forecast, By Application
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. Italy Clinical Decision Support Platform Market
      • 8.3.9.1. Market Size and Forecast, By Component
      • 8.3.9.2. Market Size and Forecast, By Delivery Mode
      • 8.3.9.3. Market Size and Forecast, By Application
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Spain Clinical Decision Support Platform Market
      • 8.3.10.1. Market Size and Forecast, By Component
      • 8.3.10.2. Market Size and Forecast, By Delivery Mode
      • 8.3.10.3. Market Size and Forecast, By Application
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. UK Clinical Decision Support Platform Market
      • 8.3.11.1. Market Size and Forecast, By Component
      • 8.3.11.2. Market Size and Forecast, By Delivery Mode
      • 8.3.11.3. Market Size and Forecast, By Application
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Clinical Decision Support Platform Market
      • 8.3.12.1. Market Size and Forecast, By Component
      • 8.3.12.2. Market Size and Forecast, By Delivery Mode
      • 8.3.12.3. Market Size and Forecast, By Application
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Component
    • 8.4.3. Market Size and Forecast, By Delivery Mode
    • 8.4.4. Market Size and Forecast, By Application
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Clinical Decision Support Platform Market
      • 8.4.7.1. Market Size and Forecast, By Component
      • 8.4.7.2. Market Size and Forecast, By Delivery Mode
      • 8.4.7.3. Market Size and Forecast, By Application
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. Japan Clinical Decision Support Platform Market
      • 8.4.8.1. Market Size and Forecast, By Component
      • 8.4.8.2. Market Size and Forecast, By Delivery Mode
      • 8.4.8.3. Market Size and Forecast, By Application
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. India Clinical Decision Support Platform Market
      • 8.4.9.1. Market Size and Forecast, By Component
      • 8.4.9.2. Market Size and Forecast, By Delivery Mode
      • 8.4.9.3. Market Size and Forecast, By Application
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. South Korea Clinical Decision Support Platform Market
      • 8.4.10.1. Market Size and Forecast, By Component
      • 8.4.10.2. Market Size and Forecast, By Delivery Mode
      • 8.4.10.3. Market Size and Forecast, By Application
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. Australia Clinical Decision Support Platform Market
      • 8.4.11.1. Market Size and Forecast, By Component
      • 8.4.11.2. Market Size and Forecast, By Delivery Mode
      • 8.4.11.3. Market Size and Forecast, By Application
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Clinical Decision Support Platform Market
      • 8.4.12.1. Market Size and Forecast, By Component
      • 8.4.12.2. Market Size and Forecast, By Delivery Mode
      • 8.4.12.3. Market Size and Forecast, By Application
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Component
    • 8.5.3. Market Size and Forecast, By Delivery Mode
    • 8.5.4. Market Size and Forecast, By Application
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Clinical Decision Support Platform Market
      • 8.5.7.1. Market Size and Forecast, By Component
      • 8.5.7.2. Market Size and Forecast, By Delivery Mode
      • 8.5.7.3. Market Size and Forecast, By Application
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. South Africa Clinical Decision Support Platform Market
      • 8.5.8.1. Market Size and Forecast, By Component
      • 8.5.8.2. Market Size and Forecast, By Delivery Mode
      • 8.5.8.3. Market Size and Forecast, By Application
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. Saudi Arabia Clinical Decision Support Platform Market
      • 8.5.9.1. Market Size and Forecast, By Component
      • 8.5.9.2. Market Size and Forecast, By Delivery Mode
      • 8.5.9.3. Market Size and Forecast, By Application
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. Rest of LAMEA Clinical Decision Support Platform Market
      • 8.5.10.1. Market Size and Forecast, By Component
      • 8.5.10.2. Market Size and Forecast, By Delivery Mode
      • 8.5.10.3. Market Size and Forecast, By Application
      • 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Cerner Corporation
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. EPIC Systems Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. IBM
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Change Healthcare Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Medical Information Technology Inc
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Koninklijke Philips NV
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Siemens Healthcare
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. Allscripts Healthcare Solutions Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. Wolters Kluwer NV
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. McKesson Corporation.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments